世界のH2拮抗薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global H2 Antagonist Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4276
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、H2拮抗薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、チュアブル、注射剤）、用途別市場規模（病院、実験室、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・H2拮抗薬の市場動向
・企業の競争状況、市場シェア
・H2拮抗薬の種類別市場規模と予測2016-2027（錠剤、チュアブル、注射剤）
・H2拮抗薬の用途別市場規模と予測2016-2027（病院、実験室、その他）
・H2拮抗薬の北米市場規模2016-2027（アメリカ、カナダ）
・H2拮抗薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・H2拮抗薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・H2拮抗薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・H2拮抗薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Tocris Bioscience、ApexBio、Medochemie、Modi Lifecare Industries Limited、GSK、Merck）
・結論

Market Analysis and Insights: Global H2 Antagonist Market
The global H2 Antagonist market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global H2 Antagonist market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global H2 Antagonist market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global H2 Antagonist market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global H2 Antagonist market.

Global H2 Antagonist Scope and Market Size
H2 Antagonist market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global H2 Antagonist market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablet
Chewable
Injectable

Segment by Application
Hospital
Laboratory
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Tocris Bioscience
ApexBio
Medochemie
Modi Lifecare Industries Limited
GSK
Merck

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global H2 Antagonist Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablet
1.2.3 Chewable
1.2.4 Injectable
1.3 Market by Application
1.3.1 Global H2 Antagonist Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global H2 Antagonist Market Perspective (2016-2027)
2.2 H2 Antagonist Growth Trends by Regions
2.2.1 H2 Antagonist Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 H2 Antagonist Historic Market Share by Regions (2016-2021)
2.2.3 H2 Antagonist Forecasted Market Size by Regions (2022-2027)
2.3 H2 Antagonist Industry Dynamic
2.3.1 H2 Antagonist Market Trends
2.3.2 H2 Antagonist Market Drivers
2.3.3 H2 Antagonist Market Challenges
2.3.4 H2 Antagonist Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top H2 Antagonist Players by Revenue
3.1.1 Global Top H2 Antagonist Players by Revenue (2016-2021)
3.1.2 Global H2 Antagonist Revenue Market Share by Players (2016-2021)
3.2 Global H2 Antagonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by H2 Antagonist Revenue
3.4 Global H2 Antagonist Market Concentration Ratio
3.4.1 Global H2 Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by H2 Antagonist Revenue in 2020
3.5 H2 Antagonist Key Players Head office and Area Served
3.6 Key Players H2 Antagonist Product Solution and Service
3.7 Date of Enter into H2 Antagonist Market
3.8 Mergers & Acquisitions, Expansion Plans

4 H2 Antagonist Breakdown Data by Type
4.1 Global H2 Antagonist Historic Market Size by Type (2016-2021)
4.2 Global H2 Antagonist Forecasted Market Size by Type (2022-2027)

5 H2 Antagonist Breakdown Data by Application
5.1 Global H2 Antagonist Historic Market Size by Application (2016-2021)
5.2 Global H2 Antagonist Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America H2 Antagonist Market Size (2016-2027)
6.2 North America H2 Antagonist Market Size by Type
6.2.1 North America H2 Antagonist Market Size by Type (2016-2021)
6.2.2 North America H2 Antagonist Market Size by Type (2022-2027)
6.2.3 North America H2 Antagonist Market Size by Type (2016-2027)
6.3 North America H2 Antagonist Market Size by Application
6.3.1 North America H2 Antagonist Market Size by Application (2016-2021)
6.3.2 North America H2 Antagonist Market Size by Application (2022-2027)
6.3.3 North America H2 Antagonist Market Size by Application (2016-2027)
6.4 North America H2 Antagonist Market Size by Country
6.4.1 North America H2 Antagonist Market Size by Country (2016-2021)
6.4.2 North America H2 Antagonist Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe H2 Antagonist Market Size (2016-2027)
7.2 Europe H2 Antagonist Market Size by Type
7.2.1 Europe H2 Antagonist Market Size by Type (2016-2021)
7.2.2 Europe H2 Antagonist Market Size by Type (2022-2027)
7.2.3 Europe H2 Antagonist Market Size by Type (2016-2027)
7.3 Europe H2 Antagonist Market Size by Application
7.3.1 Europe H2 Antagonist Market Size by Application (2016-2021)
7.3.2 Europe H2 Antagonist Market Size by Application (2022-2027)
7.3.3 Europe H2 Antagonist Market Size by Application (2016-2027)
7.4 Europe H2 Antagonist Market Size by Country
7.4.1 Europe H2 Antagonist Market Size by Country (2016-2021)
7.4.2 Europe H2 Antagonist Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific H2 Antagonist Market Size (2016-2027)
8.2 Asia-Pacific H2 Antagonist Market Size by Type
8.2.1 Asia-Pacific H2 Antagonist Market Size by Type (2016-2021)
8.2.2 Asia-Pacific H2 Antagonist Market Size by Type (2022-2027)
8.2.3 Asia-Pacific H2 Antagonist Market Size by Type (2016-2027)
8.3 Asia-Pacific H2 Antagonist Market Size by Application
8.3.1 Asia-Pacific H2 Antagonist Market Size by Application (2016-2021)
8.3.2 Asia-Pacific H2 Antagonist Market Size by Application (2022-2027)
8.3.3 Asia-Pacific H2 Antagonist Market Size by Application (2016-2027)
8.4 Asia-Pacific H2 Antagonist Market Size by Region
8.4.1 Asia-Pacific H2 Antagonist Market Size by Region (2016-2021)
8.4.2 Asia-Pacific H2 Antagonist Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America H2 Antagonist Market Size (2016-2027)
9.2 Latin America H2 Antagonist Market Size by Type
9.2.1 Latin America H2 Antagonist Market Size by Type (2016-2021)
9.2.2 Latin America H2 Antagonist Market Size by Type (2022-2027)
9.2.3 Latin America H2 Antagonist Market Size by Type (2016-2027)
9.3 Latin America H2 Antagonist Market Size by Application
9.3.1 Latin America H2 Antagonist Market Size by Application (2016-2021)
9.3.2 Latin America H2 Antagonist Market Size by Application (2022-2027)
9.3.3 Latin America H2 Antagonist Market Size by Application (2016-2027)
9.4 Latin America H2 Antagonist Market Size by Country
9.4.1 Latin America H2 Antagonist Market Size by Country (2016-2021)
9.4.2 Latin America H2 Antagonist Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa H2 Antagonist Market Size (2016-2027)
10.2 Middle East & Africa H2 Antagonist Market Size by Type
10.2.1 Middle East & Africa H2 Antagonist Market Size by Type (2016-2021)
10.2.2 Middle East & Africa H2 Antagonist Market Size by Type (2022-2027)
10.2.3 Middle East & Africa H2 Antagonist Market Size by Type (2016-2027)
10.3 Middle East & Africa H2 Antagonist Market Size by Application
10.3.1 Middle East & Africa H2 Antagonist Market Size by Application (2016-2021)
10.3.2 Middle East & Africa H2 Antagonist Market Size by Application (2022-2027)
10.3.3 Middle East & Africa H2 Antagonist Market Size by Application (2016-2027)
10.4 Middle East & Africa H2 Antagonist Market Size by Country
10.4.1 Middle East & Africa H2 Antagonist Market Size by Country (2016-2021)
10.4.2 Middle East & Africa H2 Antagonist Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Tocris Bioscience
11.1.1 Tocris Bioscience Company Details
11.1.2 Tocris Bioscience Business Overview
11.1.3 Tocris Bioscience H2 Antagonist Introduction
11.1.4 Tocris Bioscience Revenue in H2 Antagonist Business (2016-2021)
11.1.5 Tocris Bioscience Recent Development
11.2 ApexBio
11.2.1 ApexBio Company Details
11.2.2 ApexBio Business Overview
11.2.3 ApexBio H2 Antagonist Introduction
11.2.4 ApexBio Revenue in H2 Antagonist Business (2016-2021)
11.2.5 ApexBio Recent Development
11.3 Medochemie
11.3.1 Medochemie Company Details
11.3.2 Medochemie Business Overview
11.3.3 Medochemie H2 Antagonist Introduction
11.3.4 Medochemie Revenue in H2 Antagonist Business (2016-2021)
11.3.5 Medochemie Recent Development
11.4 Modi Lifecare Industries Limited
11.4.1 Modi Lifecare Industries Limited Company Details
11.4.2 Modi Lifecare Industries Limited Business Overview
11.4.3 Modi Lifecare Industries Limited H2 Antagonist Introduction
11.4.4 Modi Lifecare Industries Limited Revenue in H2 Antagonist Business (2016-2021)
11.4.5 Modi Lifecare Industries Limited Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK H2 Antagonist Introduction
11.5.4 GSK Revenue in H2 Antagonist Business (2016-2021)
11.5.5 GSK Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck H2 Antagonist Introduction
11.6.4 Merck Revenue in H2 Antagonist Business (2016-2021)
11.6.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global H2 Antagonist Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablet
Table 3. Key Players of Chewable
Table 4. Key Players of Injectable
Table 5. Global H2 Antagonist Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global H2 Antagonist Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global H2 Antagonist Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global H2 Antagonist Market Share by Regions (2016-2021)
Table 9. Global H2 Antagonist Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global H2 Antagonist Market Share by Regions (2022-2027)
Table 11. H2 Antagonist Market Trends
Table 12. H2 Antagonist Market Drivers
Table 13. H2 Antagonist Market Challenges
Table 14. H2 Antagonist Market Restraints
Table 15. Global H2 Antagonist Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global H2 Antagonist Market Share by Players (2016-2021)
Table 17. Global Top H2 Antagonist Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H2 Antagonist as of 2020)
Table 18. Ranking of Global Top H2 Antagonist Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by H2 Antagonist Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players H2 Antagonist Product Solution and Service
Table 22. Date of Enter into H2 Antagonist Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global H2 Antagonist Market Size by Type (2016-2021) (US$ Million)
Table 25. Global H2 Antagonist Revenue Market Share by Type (2016-2021)
Table 26. Global H2 Antagonist Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global H2 Antagonist Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global H2 Antagonist Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global H2 Antagonist Revenue Market Share by Application (2016-2021)
Table 30. Global H2 Antagonist Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global H2 Antagonist Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America H2 Antagonist Market Size by Type (2016-2021) (US$ Million)
Table 33. North America H2 Antagonist Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America H2 Antagonist Market Size by Application (2016-2021) (US$ Million)
Table 35. North America H2 Antagonist Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America H2 Antagonist Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America H2 Antagonist Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe H2 Antagonist Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe H2 Antagonist Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe H2 Antagonist Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe H2 Antagonist Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe H2 Antagonist Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe H2 Antagonist Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific H2 Antagonist Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific H2 Antagonist Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific H2 Antagonist Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific H2 Antagonist Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific H2 Antagonist Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific H2 Antagonist Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America H2 Antagonist Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America H2 Antagonist Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America H2 Antagonist Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America H2 Antagonist Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America H2 Antagonist Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America H2 Antagonist Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa H2 Antagonist Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa H2 Antagonist Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa H2 Antagonist Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa H2 Antagonist Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa H2 Antagonist Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa H2 Antagonist Market Size by Country (2022-2027) & (US$ Million)
Table 62. Tocris Bioscience Company Details
Table 63. Tocris Bioscience Business Overview
Table 64. Tocris Bioscience H2 Antagonist Product
Table 65. Tocris Bioscience Revenue in H2 Antagonist Business (2016-2021) & (US$ Million)
Table 66. Tocris Bioscience Recent Development
Table 67. ApexBio Company Details
Table 68. ApexBio Business Overview
Table 69. ApexBio H2 Antagonist Product
Table 70. ApexBio Revenue in H2 Antagonist Business (2016-2021) & (US$ Million)
Table 71. ApexBio Recent Development
Table 72. Medochemie Company Details
Table 73. Medochemie Business Overview
Table 74. Medochemie H2 Antagonist Product
Table 75. Medochemie Revenue in H2 Antagonist Business (2016-2021) & (US$ Million)
Table 76. Medochemie Recent Development
Table 77. Modi Lifecare Industries Limited Company Details
Table 78. Modi Lifecare Industries Limited Business Overview
Table 79. Modi Lifecare Industries Limited H2 Antagonist Product
Table 80. Modi Lifecare Industries Limited Revenue in H2 Antagonist Business (2016-2021) & (US$ Million)
Table 81. Modi Lifecare Industries Limited Recent Development
Table 82. GSK Company Details
Table 83. GSK Business Overview
Table 84. GSK H2 Antagonist Product
Table 85. GSK Revenue in H2 Antagonist Business (2016-2021) & (US$ Million)
Table 86. GSK Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck H2 Antagonist Product
Table 90. Merck Revenue in H2 Antagonist Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global H2 Antagonist Market Share by Type: 2020 VS 2027
Figure 2. Tablet Features
Figure 3. Chewable Features
Figure 4. Injectable Features
Figure 5. Global H2 Antagonist Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Laboratory Case Studies
Figure 8. Others Case Studies
Figure 9. H2 Antagonist Report Years Considered
Figure 10. Global H2 Antagonist Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global H2 Antagonist Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global H2 Antagonist Market Share by Regions: 2020 VS 2027
Figure 13. Global H2 Antagonist Market Share by Regions (2022-2027)
Figure 14. Global H2 Antagonist Market Share by Players in 2020
Figure 15. Global Top H2 Antagonist Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H2 Antagonist as of 2020
Figure 16. The Top 10 and 5 Players Market Share by H2 Antagonist Revenue in 2020
Figure 17. Global H2 Antagonist Revenue Market Share by Type (2016-2021)
Figure 18. Global H2 Antagonist Revenue Market Share by Type (2022-2027)
Figure 19. North America H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America H2 Antagonist Market Share by Type (2016-2027)
Figure 21. North America H2 Antagonist Market Share by Application (2016-2027)
Figure 22. North America H2 Antagonist Market Share by Country (2016-2027)
Figure 23. United States H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe H2 Antagonist Market Share by Type (2016-2027)
Figure 27. Europe H2 Antagonist Market Share by Application (2016-2027)
Figure 28. Europe H2 Antagonist Market Share by Country (2016-2027)
Figure 29. Germany H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific H2 Antagonist Market Share by Type (2016-2027)
Figure 37. Asia-Pacific H2 Antagonist Market Share by Application (2016-2027)
Figure 38. Asia-Pacific H2 Antagonist Market Share by Region (2016-2027)
Figure 39. China H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America H2 Antagonist Market Share by Type (2016-2027)
Figure 47. Latin America H2 Antagonist Market Share by Application (2016-2027)
Figure 48. Latin America H2 Antagonist Market Share by Country (2016-2027)
Figure 49. Mexico H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa H2 Antagonist Market Share by Type (2016-2027)
Figure 53. Middle East & Africa H2 Antagonist Market Share by Application (2016-2027)
Figure 54. Middle East & Africa H2 Antagonist Market Share by Country (2016-2027)
Figure 55. Turkey H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE H2 Antagonist Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Tocris Bioscience Revenue Growth Rate in H2 Antagonist Business (2016-2021)
Figure 59. ApexBio Revenue Growth Rate in H2 Antagonist Business (2016-2021)
Figure 60. Medochemie Revenue Growth Rate in H2 Antagonist Business (2016-2021)
Figure 61. Modi Lifecare Industries Limited Revenue Growth Rate in H2 Antagonist Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in H2 Antagonist Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in H2 Antagonist Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のアニデュラファンギン市場規模・現状・予測（2021年-2027年）

Global Anidulafungin Market Size, Status and Forecast 2021-2027
QFJ1-5581 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アニデュラファンギンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（50mg/各バイアル、100mg/各バイアル）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界のリスデキサンフェタミン市場規模・現状・予測（2021年-2027年）

Global Lisdexamfetamine Market Size, Status and Forecast 2021-2027
QFJ1-5832 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リスデキサンフェタミンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、チュアブル錠）、用途別市場規模（成人ADHD、小児ADHD、成人B.E.D.）、主要地域別市場規模（北米、アメリカ、欧州...

世界のデガレリクス市場規模・現状・予測（2021年-2027年）

Global Degarelix Market Size, Status and Forecast 2021-2027
QFJ1-5692 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、デガレリクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイアル/120mg、バイアル/80mg）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のイクサベピロン市場規模・現状・予測（2021年-2027年）

Global Ixabepilone Market Size, Status and Forecast 2021-2027
QFJ1-5813 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、イクサベピロンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（15MG/VIAL、45MG/VIAL）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のヒストレリン市場規模・現状・予測（2021年-2027年）

Global Histrelin Market Size, Status and Forecast 2021-2027
QFJ1-5781 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ヒストレリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプレリンLA、ヴァンタス）、用途別市場規模（男の子用、女の子用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のアリスキレン市場規模・現状・予測（2021年-2027年）

Global Aliskiren Market Size, Status and Forecast 2021-2027
QFJ1-5571 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、アリスキレンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（150mg錠、300mg錠）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

H2受容体拮抗薬のグローバル市場調査 2019年 The global H2 Receptor Antagonist market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on H2 Receptor Antagonist volume and value at global level, regional level and company level. From a global perspective…
世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年） Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief. Market Ana…
世界の注射式駆虫薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Injectable Anthelmintic Drugs Market The global Injectable Anthelmintic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
世界の高分子注射薬市場規模・現状・予測（2021年-2027年） Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect. Market Analysis and Insights: Global Large Molecule Injectable Drugs Market The global Large Molecule Injectable Drugs market size is projected to reach US$ …
世界の注射式標的治療市場規模・現状・予測（2021年-2027年） It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Wi…